Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation

Swiss Medical Weekly

Volumn 136, Issue 49-50, 2006, Pages 789-794

  Berthier, Céline ^a   Marti, Hans Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chronic allograft nephropathy; Chronic rejection; Cyclosporine; Extracellular matrix; Matrix metalloproteinases (MMP); Metzincins

Indexed keywords

CYCLOSPORIN A; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MEPRIN; METALLOPROTEINASE; METZINCIN; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

CARDIAC GRAFT REJECTION; CELL PROLIFERATION; CHRONIC ALLOGRAFT NEPHROPATHY; GENE EXPRESSION; GRAFT REJECTION; HISTOPATHOLOGY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; NONHUMAN; SHORT SURVEY;

EID: 33846432716     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Hamacher S, Matern S, Roeb E. Extracellular matrix - from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases. Dtsch Med Wochenschr. 2004;129(38):1976-80.
2. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J. 2005;386(Pt 1):15-27.
3. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267-85.
4. White JM. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol. 2003;15(5):598-606.
5. Bond JS, Matters GL, Banerjee S, Dusheck RE. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett. 2005;579(15): 3317-22.
6. Kruse MN, Becker C, Lottaz D, et al. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem J. 2004;378(Pt2):383-9.
7. Djamali A, Reese S, Oberley T, Hullett D, Becker B. Heat shock protein 27 in chronic allograft nephropathy: a local stress response. Transplantation. 2005;79(12):1645-57.
8. Donauer J, Rumberger B, Klein M, et al. Expression profiling on chronically rejected transplant kidneys. Transplantation. 2003;76(3):539-47.
9. Eikmans M, Roos-van Groningen MC, Sijpkens YW, et al. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value. J Am Soc Nephrol. 2005;16(12):3771-86.
10. Hotchkiss H, Chu TT, Hancock WW, et al. Differential expression of profibrotic and growth factors in chronic allograft nephropathy. Transplantation. 2006;81(3):342-9.
11. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349(2):125-38.
12. Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf E Early-prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation. 2003;75(8):1323-30.
13. Berthier CC, Lods N, Joosten SA, et al. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney Int. 2006;69(2):358-68.
14. Ermolli M, Schumacher M, Lods N, Hammoud M, Marti HP. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection. Transpl Immunol. 2003;11(2):137-45.
15. Benediktsson H, Chea R, Davidoff A, Paul LC. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation. 1996;62 (ll):1634-42.
16. Joosten SA, van Dixhoorn MG, Borrias MC, et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol. 2002;160(4): 1301-10.
17. Berthier CC, Weckbecker G, Raulf F, Marti HP. Acute rejection in experimental heart transplantation: effect of cyclosporine on matrix metalloproteinases and their inhibitors. Presented as abstract at the ATC winter conference, Banff, Canada. 2005.
18. Nikolova Z, Hof A, Baumlin Y, Hof RP. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol. 2000;8(2):115-24.
19. Alfonso-Jaume MA, Mahimkar R, Lovett DH. Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. Biochem J. 2004;380(Pt3):735-47.
20. Cohen CD, Grone HJ, Grone EF, Nelson PJ, Schlondorff D, Kretzler M, Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int. 2002;61 (1):125-32.
21. Henger A, Kretzler M, Doran P, et al. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int. 2004; 65(3):904-17.
22. Raulf F S-MP, Zhang, Dengler U, Rahuel J, Kehren J, Reinhardt M, et al. Transcriptomic Profiling for Diffferential Diagnosis of Renal Allograft Biopsies. Poster Presentation, Eighth Banff Conference on Allograft Pathology, Edmonton, Canada, July 15-21, 2005.
23. Ronco P. Predicting the outcome of human renal diseases by gene expression profiling: myth or reality? Kidney Int. 2004;65 (3):1107-8.
24. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002;346(8):580-90.
25. Schmid H HA, Irrgang S, Luckow B, Gröne HJ, Schlöndorff D, Kretzler M. A mRNA Expression Marker Set for the Differential Diagnosis of Renal Allograft Rejection. J Am Soc Nephrol. 2003;14:181A.
26. Lutz J, Yao Y, Song E, et al. Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation. 2005;79(6):655-61.
27. Rodrigo E, Lopez-Hoyos M, Escallada R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol Dial Transplant. 2000;15(12):2041-5.